The German Biotechnology Sector 2011
Higher turnover, record financing and a growing number of employees - the German biotechnology sector is growing. These are the central results of the company survey carried out at the beginning of 2011 by the information platform biotechnologie.de on behalf of the Federal Ministry of Education and Research (BMBF).
Summary
The German biotechnology sector is growing. Companies are delivering new products and efficient processes, all of which are increasingly in demand following a politically implemented energetic turnaround, as well as in the light of cost pressures in the health system. This is supported by a higher turnover of 2.4 billion euros (+9%), record financing of 700 million euros (+122%), and a growing number of employees in the commercial biotechnology sector to around 32,500 (+3%).
The total number of dedicated biotechnology companies is also rising (538). In 2010, expenditure on research and development stayed at around one billion euros (-3%).These are the central findings of the company survey carried out at the beginning of 2011 by the information platform biotechnologie.de on behalf of the Federal Ministry of Education and Research (BMBF). All of the data are in compliance with the guidelines of the Organisation for Economic Cooperation and Development (OECD; see pages 26 ff for methodology). According to the survey, at 538, the number of companies occupied primarily with biotechnology in 2010 is slightly higher than 2009 (531). Alongside this, the number of employees also rose to 15,480 (2009: 14,950). An increase could also be seen in the number of companies where biotechnology represents just one aspect of business activities. The biotech-related areas of these 125 companies (2009: 114) counted a total of 17,000 employees (2009: 16,650).
